These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 2262907)
21. Effects of thromboxane analog U46619 on endothelial damaged canine coronary arteries in vivo. Bove AA; Safford RE; Brum JM; Sufan Q; Dewey JD Prostaglandins; 1986 Nov; 32(5):665-77. PubMed ID: 3823487 [TBL] [Abstract][Full Text] [Related]
22. The effect of diltiazem, a calcium channel blocking agent, on vasoconstrictor responses to norepinephrine, serotonin and potassium depolarization in canine coronary and femoral arteries. Mullett M; Gharaibeh M; Warltier DC; Gross GJ Gen Pharmacol; 1983; 14(2):259-64. PubMed ID: 6840509 [TBL] [Abstract][Full Text] [Related]
23. Amplifying interactions between spasmogens in vascular smooth muscle. MacLennan SJ; Bolofo ML; Martin GR Biochem Soc Trans; 1993 Nov; 21(4):1145-50. PubMed ID: 8131914 [No Abstract] [Full Text] [Related]
24. Altered reactivity of coronary arteries located distal to a chronic coronary occlusion. Rapps JA; Sturek M; Jones AW; Parker JL Am J Physiol; 1997 Oct; 273(4):H1879-87. PubMed ID: 9362256 [TBL] [Abstract][Full Text] [Related]
25. Effects of S-dobutamine on venous blood return and organ nutrient blood flow. Pollock GD; Bowling N; Tuttle RR; Hayes JS J Cardiovasc Pharmacol; 1992; 20(5):742-9. PubMed ID: 1280736 [TBL] [Abstract][Full Text] [Related]
26. The effect of ethanol and serotonin on blood vessels of the rat. Malinowska B; Pietraszek M; Chabielska E; Pawlak D; Buczko W Pol J Pharmacol Pharm; 1990; 42(4):333-42. PubMed ID: 2097594 [TBL] [Abstract][Full Text] [Related]
27. Role of endothelium-derived relaxing factor and prostaglandins in responses of coronary arteries to thromboxane in vivo. Szwajkun K; Lamping KG; Dole WP Circ Res; 1990 Jun; 66(6):1729-37. PubMed ID: 2344671 [TBL] [Abstract][Full Text] [Related]
28. Vascular responses of isolated canine intermediate auricular artery to vasoactive substances. Ito T; Chiba S Arch Int Pharmacodyn Ther; 1984 Apr; 268(2):225-31. PubMed ID: 6587834 [TBL] [Abstract][Full Text] [Related]
29. Influence of the thromboxane-mimetic U-46619 and the prostacyclin metabolite 6-keto prostaglandin E1 on vasoconstriction induced by noradrenaline and 5-HT in rat mesenteric vasculature. Stanton BJ; Coupar IM Prostaglandins Leukot Essent Fatty Acids; 1988 Jul; 33(1):7-12. PubMed ID: 3186779 [TBL] [Abstract][Full Text] [Related]
30. Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Cocks TM; Angus JA Nature; 1983 Oct 13-19; 305(5935):627-30. PubMed ID: 6621711 [TBL] [Abstract][Full Text] [Related]
31. Effect of serotonin and thromboxane A2 on blood flow through moderately well developed coronary collateral vessels. Wright L; Homans DC; Laxson DD; Dai XZ; Bache RJ J Am Coll Cardiol; 1992 Mar; 19(3):687-93. PubMed ID: 1538028 [TBL] [Abstract][Full Text] [Related]
33. Enhanced contraction to noradrenaline, serotonin and nerve stimulation but normal endothelium-derived relaxing factor response in skin small arteries in human primary hypertension. Angus JA; Jennings GL; Sudhir K Clin Exp Pharmacol Physiol Suppl; 1992; 19():39-47. PubMed ID: 1395116 [TBL] [Abstract][Full Text] [Related]
34. Action of cocaine on norepinephrine- and calcium-induced contraction of vascular smooth muscle. D'Agostino G; Zonta F; Dondi G; Grana E Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):89-98. PubMed ID: 6870390 [TBL] [Abstract][Full Text] [Related]
35. Contraction of bovine coronary vascular smooth muscle induced by cocaine is not mediated by norepinephrine. Foy RA; Myles JL; Wilkerson RD Life Sci; 1991; 49(4):299-308. PubMed ID: 2072818 [TBL] [Abstract][Full Text] [Related]
36. Effects of naftidrofuryl on adrenergic nerves, endothelium and smooth muscle in isolated canine blood vessels. Zander JF; Aarhus LL; Katusic ZS; Rubanyi GM; Vanhoutte PM J Pharmacol Exp Ther; 1986 Dec; 239(3):760-7. PubMed ID: 3025417 [TBL] [Abstract][Full Text] [Related]
37. Effects of the thromboxane receptor antagonist SK&F 88046 in the canine, monkey and human coronary vasculature. Ohlstein EH; Kopia GA; Zeid RL; Valocik RW; Horohonich S; Hieble JP; Wasserman MA Prostaglandins; 1988 Jul; 36(1):69-84. PubMed ID: 3175024 [TBL] [Abstract][Full Text] [Related]
38. Synergistic effects of LTC4 and TxA2 on coronary flow and myocardial function. Nichols WW; Mehta JL; Thompson L; Donnelly WH Am J Physiol; 1988 Jul; 255(1 Pt 2):H153-9. PubMed ID: 3394816 [TBL] [Abstract][Full Text] [Related]
39. In vitro modulation of primate coronary vascular muscle cell reactivity by ovarian steroid hormones. Minshall RD; Miyagawa K; Chadwick CC; Novy MJ; Hermsmeyer K FASEB J; 1998 Oct; 12(13):1419-29. PubMed ID: 9761786 [TBL] [Abstract][Full Text] [Related]
40. Heterogeneity of vascular smooth muscle responsiveness to lipid vasoactive mediators. Stahl GL; Lefer AM Blood Vessels; 1987; 24(1-2):24-30. PubMed ID: 3567363 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]